Allergy and risk of acute lymphoblastic leukemia among children: A nationwide case control study in Greece

Cancer Epidemiology

Volumn 37, Issue 2, 2013, Pages 146-151

  Lariou, Maria Stella ^a   Dikalioti, Stavroula K ^a   Dessypris, Nick ^a   Baka, Margarita ^b   Polychronopoulou, Sophia ^c   Athanasiadou Piperopoulou, Fani ^d   Kalmanti, Maria ^e   Fragandrea, Ioanna ^a   Moschovi, Maria ^a   Germenis, Anastasios E ^f   Petridou, Eleni T ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b P AND A KYRIAKOU CHILDREN S HOSPITAL   (Greece)

^c AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^d ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^e UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^f UNIVERSITY HOSPITAL OF LARISSA   (Greece)

Author keywords

Allergy; Childhood; Food and respiratory allergens; IgE; Leukemia

Indexed keywords

FOOD ALLERGEN; IMMUNOGLOBULIN E ANTIBODY;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ANTIBODY BLOOD LEVEL; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CHILD; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG HYPERSENSITIVITY; ECZEMA; ENZYME IMMUNOASSAY; FEMALE; FOOD ALLERGY; GREECE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NEWBORN; PEDIATRIC HOSPITAL; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPIRATORY TRACT ALLERGY; SCHOOL CHILD; SELF REPORT; URTICARIA;

ADULT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; GREECE; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; INCIDENCE; MALE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PREVALENCE; PROGNOSIS; REGISTRIES; RISK FACTORS; YOUNG ADULT;

EID: 84875811132     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2012.10.012     Document Type: Article

References (65)

1. Bhatia S., Robinson L.L. Epidemiology of leukemia in childhood. Nathan and Oski's hematology of infancy and childhood 2003, 1081-1100. Saunders, Philadelphia, PA. D.G. Nathan, S.H. Orkin, A.T. Look, D. Ginsburg (Eds.).
2. Steliarova-Foucher E., Stiller C., Kaatsch P., Berrino F., Coebergh J.W., Lacour B., et al. Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCISproject): an epidemiological study. Lancet 2004, 364(9451):2097-2105.
3. Linabery A.M., Ross J.A. Trends in childhood cancer incidence in the U.S. (1992-2004). Cancer 2008, 112(2):416-432.
4. Clavel J., Goubin A., Auclerc M.F., Auvrignon A., Waterkeyn C., Patte C., et al. Incidence of childhood leukaemia and non-Hodgkin's lymphoma in France: National Registry of Childhood Leukaemia and Lymphoma, 1990-1999. Eur J Cancer Prev 2004, 13(2):97-103.
5. Gonzalez J.R., Fernandez E., de Toledo J.S., Galceran J., Peris M., Gispert R., et al. Trends in childhood cancer incidence and mortality in Catalonia, Spain, 1975-1998. Eur J Cancer Prev 2004, 13(1):47-51.
6. Hjalgrim L.L., Rostgaard K., Schmiegelow K., Soderhall S., Kolmannskog S., Vettenranta K., et al. Age- and sex-specific incidence of childhood leukemia by immunophenotype in the Nordic countries. J Natl Cancer Inst 2003, 95(20):1539-1544.
7. Stack M., Walsh P.M., Comber H., Ryan C.A., O'Lorcain P. Childhood cancer in Ireland: a population-based study. Arch Dis Child 2007, 92(10):890-897.
8. Steliarova-Foucher E., Stiller C., Kaatsch P., Berrino F., Coebergh J.W. Trends in childhood cancer incidence in Europe, 1970-1999. Lancet 2005, 365(9477):2088.
9. Petridou E.T., Pourtsidis A., Dessypris N., Katsiardanis K., Baka M., Moschovi M., et al. Childhood leukaemias and lymphomas in Greece (1996-2006): a nationwide registration study. Arch Dis Child 2008, 93(12):1027-1032.
10. Adamson P., Law G., Roman E. Assessment of trends in childhood cancer incidence. Lancet 2005, 365(9461):753.
11. Manda S.O., Feltbower R.G., Gilthorpe M.S. Investigating spatio-temporal similarities in the epidemiology of childhood leukaemia and diabetes. Eur J Epidemiol 2009, 24(12):743-752.
12. Badham H.J., Winn L.M. In utero exposure to benzene disrupts fetal hematopoietic progenitor cell growth via reactive oxygen species. Toxicol Sci 2010, 113(1):207-215.
13. Papaemmanuil E., Hosking F.J., Vijayakrishnan J., Price A., Olver B., Sheridan E., et al. Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia. Nat Genet 2009, 41(9):1006-1010.
14. Sherborne A.L., Hemminki K., Kumar R., Bartram C.R., Stanulla M., Schrappe M., et al. Rationale for an international consortium to study inherited genetic susceptibility to childhood acute lymphoblastic leukemia. Haematologica 2011, 96(7):1049-1054.
15. Sherborne A.L., Hosking F.J., Prasad R.B., Kumar R., Koehler R., Vijayakrishnan J., et al. Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk. Nat Genet 2010, 42(6):492-494.
16. Trevino L.R., Yang W., French D., Hunger S.P., Carroll W.L., Devidas M., et al. Germline genomic variants associated with childhood acute lymphoblastic leukemia. Nat Genet 2009, 41(9):1001-1005.
17. Vijayakrishnan J., Houlston R.S. Candidate gene association studies and risk of childhood acute lymphoblastic leukemia: a systematic review and meta-analysis. Haematologica 2010, 95(8):1405-1414.
18. Borst L., Wesolowska A., Joshi T., Borup R., Nielsen F.C., Andersen M.K., et al. Genome-wide analysis of cytogenetic aberrations in ETV6/RUNX1-positive childhood acute lymphoblastic leukaemia. Br J Haematol 2012, 157(4):476-482.
19. Almalte Z., Samarani S., Iannello A., Debbeche O., Duval M., Infante-Rivard C., et al. Novel associations between activating killer-cell immunoglobulin-like receptor genes and childhood leukemia. Blood 2011, 118(5):1323-1328.
20. Asher M.I., Montefort S., Bjorksten B., Lai C.K., Strachan D.P., Weiland S.K., et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 2006, 368(9537):733-743.
21. Priftis K., Panagiotopoulou-Gartagani P., Tapratzi-Potamianou P., Zachariadi-Xypolita A., Sagriotis A., Saxoni-Papageorgiou P. Hospitalizations for childhood asthma in Athens, Greece, from 1978 to 2000. Pediatr Allergy Immunol 2005, 16(1):82-85.
22. Anthracopoulos M.B., Liolios E., Panagiotakos D.B., Triantou K., Priftis K.N. Prevalence of asthma among schoolchildren in Patras, Greece: four questionnaire surveys during 1978-2003. Arch Dis Child 2007, 92(3):209-212.
23. Pearce N., Douwes J. The global epidemiology of asthma in children. Int J Tuberc Lung Dis 2006, 10(2):125-132.
24. Anthracopoulos M.B., Antonogeorgos G., Liolios E., Triga M., Panagiotopoulou E., Priftis K.N. Increase in chronic or recurrent rhinitis, rhinoconjunctivitis and eczema among schoolchildren in Greece: three surveys during 1991-2003. Pediatr Allergy Immunol 2009, 20(2):180-186.
25. Ege M.J., Mayer M., Normand A.C., Genuneit J., Cookson W.O., Braun-Fahrlander C., et al. Exposure to environmental microorganisms and childhood asthma. N Engl J Med 2011, 364(8):701-709.
26. McNally R.J., Eden T.O. An infectious aetiology for childhood acute leukaemia: a review of the evidence. Br J Haematol 2004, 127(3):243-263.
27. Perrillat F., Clavel J., Auclerc M.F., Baruchel A., Leverger G., Nelken B., et al. Day-care, early common infections and childhood acute leukaemia: a multicentre French case-control study. Br J Cancer 2002, 86(7):1064-1069.
28. Jourdan-Da Silva N., Perel Y., Mechinaud F., Plouvier E., Gandemer V., Lutz P., et al. Infectious diseases in the first year of life, perinatal characteristics and childhood acute leukaemia. Br J Cancer 2004, 90(1):139-145.
29. Rudant J., Orsi L., Menegaux F., Petit A., Baruchel A., Bertrand Y., et al. Childhood acute leukemia, early common infections, and allergy: the ESCALE Study. Am J Epidemiol 2010, 172(9):1015-1027.
30. Roman E., Simpson J., Ansell P., Kinsey S., Mitchell C.D., McKinney P.A., et al. Childhood acute lymphoblastic leukemia and infections in the first year of life: a report from the United Kingdom Childhood Cancer Study. Am J Epidemiol 2007, 165(5):496-504.
31. Cardwell C.R., McKinney P.A., Patterson C.C., Murray L.J. Infections in early life and childhood leukaemia risk: a UK case-control study of general practitioner records. Br J Cancer 2008, 99(9):1529-1533.
32. Martinez F.D. Respiratory syncytial virus bronchiolitis and the pathogenesis of childhood asthma. Pediatr Infect Dis J 2003, 22(2 Suppl.):S76-S82.
33. Wu P., Hartert T.V. Evidence for a causal relationship between respiratory syncytial virus infection and asthma. Expert Rev Anti Infect Ther 2011, 9(9):731-745.
34. Bartlett N.W., McLean G.R., Chang Y.S., Johnston S.L. Genetics and epidemiology: asthma and infection. Curr Opin Allergy Clin Immunol 2009, 9(5):395-400.
35. Jartti T., Korppi M. Rhinovirus-induced bronchiolitis and asthma development. Pediatr Allergy Immunol 2011, 22(4):350-355.
36. Nishi M., Miyake H. A case-control study of non-T cell acute lymphoblastic leukaemia of children in Hokkaido, Japan. J Epidemiol Community Health 1989, 43(4):352-355.
37. Petridou E., Trichopoulos D., Kalapothaki V., Pourtsidis A., Kogevinas M., Kalmanti M., et al. The risk profile of childhood leukaemia in Greece: a nationwide case-control study. Br J Cancer 1997, 76(9):1241-1247.
38. Rosenbaum P.F., Buck G.M., Brecher M.L. Allergy and infectious disease histories and the risk of childhood acute lymphoblastic leukaemia. Paediatr Perinat Epidemiol 2005, 19(2):152-164.
39. Schuz J., Morgan G., Bohler E., Kaatsch P., Michaelis J. Atopic disease and childhood acute lymphoblastic leukemia. Int J Cancer 2003, 105(2):255-260.
40. Linabery A.M., Jurek A.M., Duval S., Ross J.A. The association between atopy and childhood/adolescent leukemia: a meta-analysis. Am J Epidemiol 2010, 171(7):749-764.
41. Hughes A.M., Lightfoot T., Simpson J., Ansell P., McKinney P.A., Kinsey S.E., et al. Allergy and risk of childhood leukaemia: results from the UKCCS. Int J Cancer 2007, 121(4):819-824.
42. NARECHEM - Nationwide Registry of Childhood Hematological Malignancies. [cited 26th May 2011].
43. Petridou E., Mantzoros C.S., Dessypris N., Dikalioti S.K., Trichopoulos D. Adiponectin in relation to childhood myeloblastic leukaemia. Br J Cancer 2006, 94(1):156-160.
44. SAS Institute Inc. SAS/STAT user's guide, Version 6, 4th ed. Cary, NC; 1989.
45. Wiemels J.L., Wiencke J.K., Patoka J., Moghadassi M., Chew T., McMillan A., et al. Reduced immunoglobulin E and allergy among adults with glioma compared with controls. Cancer Res 2004, 64(22):8468-8473.
46. Martin Ibanez I., Arce Casas A., Cruz Martinez O., Estella Aguado J., Martin Mateos M.A. Humoral immunity in pediatric patients with acute lymphoblastic leukaemia. Allergol et Immunopathol 2003, 31(6):303-310.
47. Kamp D.W., Shacter E., Weitzman S.A. Chronic inflammation and cancer: the role of the mitochondria. Oncology (Williston Park) 2011, 25(5). 400-10, 413.
48. Porta C., Larghi P., Rimoldi M., Totaro M.G., Allavena P., Mantovani A., et al. Cellular and molecular pathways linking inflammation and cancer. Immunobiology 2009, 214(9-10):761-777.
49. Apte R.N., Voronov E. Interleukin-1-a major pleiotropic cytokine in tumor-host interactions. Semin Cancer Biol 2002, 12(4):277-290.
50. Benchetrit F., Ciree A., Vives V., Warnier G., Gey A., Sautes-Fridman C., et al. Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism. Blood 2002, 99(6):2114-2121.
51. Cerundolo V., Silk J.D., Masri S.H., Salio M. Harnessing invariant NKT cells in vaccination strategies. Nat Rev Immunol 2009, 9(1):28-38.
52. Meyer E.H., DeKruyff R.H., Umetsu D.T. iNKT cells in allergic disease. Curr Top Microbiol Immunol 2007, 314:269-291.
53. Meyer E.H., DeKruyff R.H., Umetsu D.T. T cells and NKT cells in the pathogenesis of asthma. Annu Rev Med 2008, 59:281-292.
54. Oki S., Miyake S. Invariant natural killer T (iNKT) cells in asthma: a novel insight into the pathogenesis of asthma and the therapeutic implication of glycolipid ligands for allergic diseases. Allergol Int 2007, 56(1):7-14.
55. Holly E.A., Lele C., Bracci P.M., McGrath M.S. Case-control study of non-Hodgkin's lymphoma among women and heterosexual men in the San Francisco Bay Area, California. Am J Epidemiol 1999, 150(4):375-389.
56. Hellstrand K. Histamine in cancer immunotherapy: a preclinical background. Semin Oncol 2002, 29(3 Suppl. 7):35-40.
57. Perz J.B., Ho A.D. Histamine dihydrochloride for the treatment of acute myeloid leukemia, malignant melanoma and renal cell carcinoma. Future Oncol 2008, 4(2):169-177.
58. Yang L.P., Perry C.M. Histamine dihydrochloride: in the management of acute myeloid leukaemia. Drugs 2011, 71(1):109-122.
59. Wang H., Diepgen T.L. Is atopy a protective or a risk factor for cancer? A review of epidemiological studies. Allergy 2005, 60(9):1098-1111.
60. Amoudruz P., Holmlund U., Malmstrom V., Trollmo C., Bremme K., Scheynius A., et al. Neonatal immune responses to microbial stimuli: is there an influence of maternal allergy?. J Allergy Clin Immunol 2005, 115(6):1304-1310.
61. Schaub B., Campo M., He H., Perkins D., Gillman M.W., Gold D.R., et al. Neonatal immune responses to TLR2 stimulation: influence of maternal atopy on Foxp3 and IL-10 expression. Respir Res 2006, 7:40.
62. Schaub B., Liu J., Hoppler S., Haug S., Sattler C., Lluis A., et al. Impairment of T-regulatory cells in cord blood of atopic mothers. J Allergy Clin Immunol 2008, 121(6). 1491-99, 1499.e1-13.
63. Chang J.S., Buffler P.A., Metayer C., Chokkalingam A.P., Patoka J., Kronish D., et al. Maternal immunoglobulin E and childhood leukemia. Cancer Epidemiol Biomarkers Prev 2009, 18(8):2221-2227.
64. Grulich A.E., Vajdic C.M., Kaldor J.M., Hughes A.M., Kricker A., Fritschi L., et al. Birth order, atopy, and risk of non-Hodgkin lymphoma. J Natl Cancer Inst 2005, 97(8):587-594.
65. CLIC, Childhood Leukemia International Consortium, Available from: ; 2012 [cited 25th October 2012]. https://ccls.berkeley.edu/clic/about.